GABAergic neuronal precursor grafting: implications in brain regeneration and plasticity
- PMID: 21766042
- PMCID: PMC3135013
- DOI: 10.1155/2011/384216
GABAergic neuronal precursor grafting: implications in brain regeneration and plasticity
Abstract
Numerous neurological disorders are caused by a dysfunction of the GABAergic system that impairs or either stimulates its inhibitory action over its neuronal targets. Pharmacological drugs have generally been proved very effective in restoring its normal function, but their lack of any sort of spatial or cell type specificity has created some limitations in their use. In the last decades, cell-based therapies using GABAergic neuronal grafts have emerged as a promising treatment, since they may restore the lost equilibrium by cellular replacement of the missing/altered inhibitory neurons or modulating the hyperactive excitatory system. In particular, the discovery that embryonic ganglionic eminence-derived GABAergic precursors are able to disperse and integrate in large areas of the host tissue after grafting has provided a strong rationale for exploiting their use for the treatment of diseased brains. GABAergic neuronal transplantation not only is efficacious to restore normal GABAergic activities but can also trigger or sustain high neuronal plasticity by promoting the general reorganization of local neuronal circuits adding new synaptic connections. These results cast new light on dynamics and plasticity of adult neuronal assemblies and their associated functions disclosing new therapeutic opportunities for the near future.
References
-
- Olsen RW. GABA. In: Davis KL, et al., editors. Neuropsychopharmacology: The Fifth Generation of Progress. American College of Neuropsychopharmacology; 2002. pp. 159–168.
-
- Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. International Review of Cytology. 2002;213:1–47. - PubMed
-
- Gajcy K, Lochynski S, Librowski T. A role of GABA analogues in the treatment of neurological diseases. Current Medicinal Chemistry. 2010;17(22):2338–2347. - PubMed
-
- Galvan A, Wichmann T. GABAergic circuits in the basal ganglia and movement disorders. Progress in Brain Research. 2007;160:287–312. - PubMed
-
- Kleppner SR, Tobin AJ. GABA signalling: therapeutic targets for epilepsy, Parkinson's disease and Huntington's disease. Expert Opinion on Therapeutic Targets. 2001;5(2):219–239. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous